174 related articles for article (PubMed ID: 23101592)
1. Comparison between the polymerase chain reaction-based screening and the Southern blot methods for identification of fragile X syndrome.
Curtis-Cioffi KM; Rodrigueiro DA; Rodrigues VC; Cicarelli RM; Scarel-Caminaga RM
Genet Test Mol Biomarkers; 2012 Nov; 16(11):1303-8. PubMed ID: 23101592
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the human fragile X mental retardation 1 polymerase chain reaction reagents to amplify the FMR1 gene: testing in a clinical diagnostic laboratory.
Nahhas FA; Monroe TJ; Prior TW; Botma PI; Fang J; Snyder PJ; Talbott SL; Feldman GL
Genet Test Mol Biomarkers; 2012 Mar; 16(3):187-92. PubMed ID: 21992462
[TBL] [Abstract][Full Text] [Related]
3. Clinical Genetic Testing for Fragile X Syndrome by Polymerase Chain Reaction Amplification and Southern Blot Analyses.
Cai X; Arif M; Wan H; Kornreich R; Edelmann LJ
Methods Mol Biol; 2019; 1942():11-27. PubMed ID: 30900172
[TBL] [Abstract][Full Text] [Related]
4. Multiplex methylation specific PCR analysis of fragile X syndrome: experience in Songklanagarind Hospital.
Charalsawadi C; Sripo T; Limprasert P
J Med Assoc Thai; 2005 Aug; 88(8):1057-61. PubMed ID: 16404832
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of blood spot PCR in large-scale screening of fragile X syndrome in southern Taiwan.
Chow JC; Chen DJ; Lin CN; Chiu CY; Huang CB; Chiu PC; Lin CH; Lin SJ; Tzeng CC
J Formos Med Assoc; 2003 Jan; 102(1):12-6. PubMed ID: 12684606
[TBL] [Abstract][Full Text] [Related]
6. A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene.
Wang H; Zhu X; Gui B; Cheung WC; Shi M; Yang Z; Kwok KY; Lim R; Pietilä S; Zhu Y; Choy KW
J Vis Exp; 2019 Sep; (151):. PubMed ID: 31566610
[TBL] [Abstract][Full Text] [Related]
7. Detection of Cryptic Fragile X Full Mutation Alleles by Southern Blot in a Female and Her Foetal DNA via Chorionic Villus Sampling, Complicated by Mosaicism for 45,X0/46,XX/47,XXX.
Pandelache A; Francis D; Oertel R; Dickson R; Sachdev R; Ling L; Gamage D; Godler DE
Genes (Basel); 2021 May; 12(6):. PubMed ID: 34073864
[TBL] [Abstract][Full Text] [Related]
8. An effective strategy of using molecular testing to screen mentally retarded individuals for fragile X syndrome.
Tzeng CC; Lin SJ; Chen YJ; Kuo PL; Jong YJ; Tsai LP; Chen RM
Diagn Mol Pathol; 2001 Mar; 10(1):34-40. PubMed ID: 11277393
[TBL] [Abstract][Full Text] [Related]
9. Simple molecular diagnostic method for fragile X syndrome in Egyptian patients: pilot study.
Meguid NA; Ismail MF; El-Mahdy RS; Barakat MA; El-Awady MK
Acta Biochim Pol; 2014; 61(2):259-63. PubMed ID: 24936518
[TBL] [Abstract][Full Text] [Related]
10. Pilot fragile X screening in normal population of Taiwan.
Tzeng CC; Cho WC; Kuo PL; Chen RM
Diagn Mol Pathol; 1999 Sep; 8(3):152-6. PubMed ID: 10565687
[TBL] [Abstract][Full Text] [Related]
11. FMR1 gene mutations in patients with fragile X syndrome and obligate carriers: 30 years of experience in Chile.
Santa María L; Aliaga S; Faundes V; Morales P; Pugin Á; Curotto B; Soto P; Peña MI; Salas I; Alliende MA
Genet Res (Camb); 2016 Jun; 98():e11. PubMed ID: 27350105
[TBL] [Abstract][Full Text] [Related]
12. Simplified strategy for rapid first-line screening of fragile X syndrome: closed-tube triplet-primed PCR and amplicon melt peak analysis.
Rajan-Babu IS; Law HY; Yoon CS; Lee CG; Chong SS
Expert Rev Mol Med; 2015 May; 17():e7. PubMed ID: 25936533
[TBL] [Abstract][Full Text] [Related]
13. Fragile X syndrome screening in pregnant women and women planning pregnancy shows a remarkably high FMR1 premutation prevalence in the Balearic Islands.
Alfaro Arenas R; Rosell Andreo J; Heine Suñer D;
Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1023-1031. PubMed ID: 27333191
[TBL] [Abstract][Full Text] [Related]
14. Molecular screening of intellectually disabled patients and those with premature ovarian failure for CGG repeat expansion at FMR1 locus: Implication of combined triplet repeat primed polymerase chain reaction and methylation-specific polymerase chain reaction analysis.
Muthuswamy S; Dean DD; Agarwal S
Neurol India; 2016; 64(6):1175-1179. PubMed ID: 27841182
[TBL] [Abstract][Full Text] [Related]
15. Accuracy and Performance Evaluation of Triplet Repeat Primed PCR as an Alternative to Conventional Diagnostic Methods for Fragile X Syndrome.
Gu H; Kim MJ; Yang D; Song JY; Cho SI; Park SS; Seong MW
Ann Lab Med; 2021 Jul; 41(4):394-400. PubMed ID: 33536358
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic testing in fragile X syndrome].
Sireteanu A; Rusu C
Rev Med Chir Soc Med Nat Iasi; 2006; 110(4):968-71. PubMed ID: 17438909
[TBL] [Abstract][Full Text] [Related]
17. Simplified molecular diagnosis of fragile X syndrome by fluorescent methylation-specific PCR and GeneScan analysis.
Zhou Y; Lum JM; Yeo GH; Kiing J; Tay SK; Chong SS
Clin Chem; 2006 Aug; 52(8):1492-500. PubMed ID: 16793928
[TBL] [Abstract][Full Text] [Related]
18. Advanced technologies for the molecular diagnosis of fragile X syndrome.
Tassone F
Expert Rev Mol Diagn; 2015; 15(11):1465-73. PubMed ID: 26489042
[TBL] [Abstract][Full Text] [Related]
19. Development of a novel, accurate, automated, rapid, high-throughput technique suitable for population-based carrier screening for Fragile X syndrome.
Strom CM; Huang D; Li Y; Hantash FM; Rooke J; Potts SJ; Sun W
Genet Med; 2007 Apr; 9(4):199-207. PubMed ID: 17438383
[TBL] [Abstract][Full Text] [Related]
20. Validation of a Screening Method for Dynamic Mutations in the
Škrlec I; Barišić K; Wagner J
Ann Clin Lab Sci; 2018 Nov; 48(6):810-813. PubMed ID: 30610057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
